Class IIOngoing
Aurolab Trust recalls FOCUS PI Hypromellose 0
Recall date · record updated Oct 7, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- Aurolab Trust
- Reason
- Lack of Assurance of Sterility
- Hazard
- FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
- Who’s affected
- VA
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99903…
Products
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
Codes/lots: Batch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28Quantity: 25,220 bottlesRecall no. D-0874-2026Class II
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass II
American Health Packaging recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide
Medicines & devicesClass II
Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection
Failed Impurities/Degradation Specifications.
· FDA · Nationwide
Medicines & devicesClass II
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide